Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Medifast's Enterprise Value is €-39.7 Mil.
Medifast's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was €3.1 Mil. Therefore, Medifast's EV-to-OCF for today is -12.78.
The historical rank and industry rank for Medifast's EV-to-OCF or its related term are showing as below:
FRA:MDF'
s EV-to-OCF Range Over the Past 10 Years
Min: -12.46 Med: 14.33 Max: 47.98
Current: -12.16
During the past 13 years, the highest EV-to-OCF of Medifast was 47.98. The lowest was -12.46. And the median was 14.33.
FRA:MDF's EV-to-OCF is ranked better than 89.69% of 97
companies
in the Personal Services industry
Industry Median: 8.07
vs FRA:MDF: -12.16
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medifast's share price for today is €7.86.
Medifast's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.561.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Medifast EV-to-OCF Related Terms
Medifast EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Medifast's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Personal Services subindustry, Medifast's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medifast EV-to-OCF vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, Medifast's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Medifast's EV-to-OCF falls into.
Medifast's current Enterprise Value is €-39.7 Mil.
Medifast's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medifast (FRA:MDF) has a EV-to-OCF of -12.78 as of Jul. 26, 2026. According to the industry distribution chart, Medifast ranks #10 out of 97 companies in the Personal Services industry, placing it in the top 10.3%.
Is Medifast's EV-to-OCF too high?
Medifast's current EV-to-OCF is -12.78. Based on the distribution chart, Medifast ranks #10 out of 97 companies in the Personal Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medifast has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Medifast's EV-to-OCF compare to RGS and EVTK?
According to the Personal Services industry distribution chart, Medifast ranks #10 out of 97 companies for EV-to-OCF. This places Medifast in the top 10% of its industry — outperforming the majority of peers. The industry median EV-to-OCF is 8.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Personal Services company?
The median EV-to-OCF among Personal Services companies is 8.07, based on 97 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Personal Services industry, the median EV-to-OCF is 8.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medifast's current EV-to-OCF is -12.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Medifast (FRA:MDF) has a current EV-to-OCF of -12.78. The stock's GF Value™ is €6.94, compared to a current price of €7.86 — trading 13.3% above its estimated fair value. The current EV-to-OCF is -12.78. Medifast's overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Medifast (FRA:MDF), the current EV-to-OCF is -12.78 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medifast (FRA:MDF) Overvalued in 2026?
Based on GuruFocus' analysis, Medifast stock appears to be overvalued.
The current stock price of €7.86 is trading 13.3% above its estimated GF Value™ of €6.94.
Key valuation signals for FRA:MDF:
EV-to-OCF: -12.78
GF Value™: €6.94 vs. price of €7.86 (13.3% above fair value)
No single metric tells the full story. See the FRA:MDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
66GF Score
Get the complete analysis for FRA:MDF
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MDF has been successfully added to your 
